Company / Operating Margin
Whitehawk Therapeutics, Inc. Operating Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-259.6%
FY2025
5-year range
-794.4% / -17.5%
FY2021-FY2025
Trend
+12.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has increased for 3 consecutive years, from -794.4% in FY2022 to -259.6% in FY2025.
Based on SEC 10-K filings.
-259.6% in FY2025 with a 3-year CAGR of +534.8%.
Improved from -447.7% to -259.6% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +534.8pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- Whitehawk Therapeutics, Inc.'s operating margin has grown for 3 consecutive years.
- In FY2025, operating margin increased 12.1% year-over-year.
- Peak operating margin was recorded in FY2021.
- Lowest operating margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -259.6% | +12.1% |
| FY2024 | -295.4% | +34.0% |
| FY2023 | -447.7% | +43.6% |
| FY2022 | -794.4% | -4444.7% |
| FY2021 | -17.5% | - |
| FY2020 | - | - |
| FY2019 | -55.5% | +96.5% |
| FY2018 | -1604.1% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026